M62 is an annual hybrid meeting, hosted by the Manchester Centre for Genomic Medicine which brings together clinicians across the M62 corridor to review dysmorphic and developmental cases, enhance shared learning, and promote consistent, high-quality diagnostic approaches. Each year the meeting aims to strengthen regional collaboration, improve recognition of dysmorphic patterns, and support optimal patient pathways.
Attendance at these meetings is aimed at specialists who may be involved in the management of patients with skeletal dysplasias including geneticists, radiologists, orthopaedic surgeons, endocrinologists and metabolic physicians. It is an informal forum allowing attendees to present cases for discussion regarding known and unknown diagnoses or clinical management issues.
Previously, M62 meetings have covered a broad range of clinical and translational genomics topics, including therapeutic strategies for genetic disorders, genome sequencing applications, epigenetic mechanisms such as methylation and chromatin disorders, and the interpretation and reanalysis of genomic data.
By attending M62 meetings, delegates engage with real-world case presentations and focused discussions which have previously entered around fetal loss genomics and overgrowth syndromes (including PIK3CA-related conditions), highlighting how genomic insights inform diagnosis, management, and patient care.
Each year the M62 meeting is designed and delivered by Dr Laura Furness (ST6 Clinical Genomics) and Dr Olga Tsoulaki (ST6 Clinical Genomics)
If you have any queries or questions regarding the M62 annual meeting please contact mrcc@mft.nhs.uk
Dr Laura Furness
ST6 Clinical Genomics
Dr Olga Tsoulaki
ST6 Clinical Genomics
Previous M62 Meeting Materials and Agendas
